1. A pharmaceutical combination comprising a compound of formula 1! ! and trastuzumab. ! 2. The pharmaceutical combination according to claim 1, additionally containing hematopoietic growth factors. ! 3. The use of the compounds of formula (1) to obtain a pharmaceutical combination according to claim 1 for the treatment of taxoid-resistant cancers.
展开▼